Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilioinguinal Nerve Block in Inguinal Hernia Repair
NCT07049835Phase 1Active, not recruiting
- Sponsor
- Makassed General Hospital
- Start
- Jun 2025
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Makassed General Hospital. Primary endpoint: Postoperative Pain Scores at 24 hours. Started Jun 2025; status: active, not recruiting.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07049835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07049835.